NEWS

Today we proudly launch our Multinational Healthcare Investment in Norway: Fulfilling Potential report, assessing Norway’s ability to grow its engagement within a life-saving – and particularly competitive – global industry. We thank all industry leaders who have contributed with their first-hand insight and healthcare perspectives on Norway’s greatest existing barriers – and most promising recommendations for growth.

Available in both English and Norwegian, the report was authored by Oslo Economics’  Erik Magnus Sæther and his team on behalf of AmCham Norway.

Thank you to AmCham members who supported this publication:  Abbvie, Amgen, Biogen, Bristol Myers Squibb, GSK, Janssen, MSD, Pfizer, Roche, Sanofi, Takeda, and Thermo Fisher.

Read the report HERE.